Published in:
Open Access 01-12-2008 | Case report
Nail changes secondary to docetaxel chemotherapy : a case report
Published in: Journal of Medical Case Reports | Issue 1/2008
Login to get accessAbstract
Introduction
Docetaxel is a chemotherapy agent used in the management of many neoplastic conditions. Various side effects are known. Nail changes are often under-recognised or attributed to other causes.
Case presentation
We report the case of a 66 year old gentleman who received docetaxel chemotherapy for non-small cell lung cancer. He had nail changes as a complication of the treatment.
Conclusion
Nail toxicity is a recognised side-effect of taxane chemotherapy agents and can often persist for many months after finishing the treatment. We would like to highlight this problem, so it can be considered as a differential diagnosis in the appropriate population.